Eligibility Cannot be Raised in IPR Appeal  Patently-O

Neptune Generics v. Eli Lilly (Fed. Cir. 2019) Mylan Labs v. Eli Lilly (Fed. Cir. 2019). This appeal combines twelve different inter partes review (IPR) proceedings.